Related references
Note: Only part of the references are listed.The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice
Emily A. Day et al.
BIOCHEMICAL JOURNAL (2020)
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering
Carmen Haerdtner et al.
BASIC RESEARCH IN CARDIOLOGY (2020)
De novo lipogenesis is essential for platelet production in humans
Kenneth L. Kelly et al.
NATURE METABOLISM (2020)
Inhibition of Adenosine Monophosphate-Activated Protein Kinase-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Signaling Leads to Hypercholesterolemia and Promotes Hepatic Steatosis and Insulin Resistance
Kim Loh et al.
HEPATOLOGY COMMUNICATIONS (2019)
The expanded role of fatty acid metabolism in cancer: new aspects and targets
Ming Chen et al.
PRECISION CLINICAL MEDICINE (2019)
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
Ryan M. Esquejo et al.
EBIOMEDICINE (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation
Miao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National Lipid Association
Jerome D. Cohen et al.
Journal of Clinical Lipidology (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Aspirin inhibits LPS-induced macrophage activation via the NF-κB pathway
Yitong Liu et al.
SCIENTIFIC REPORTS (2017)
PCSK9 inhibitor access barriersissues and recommendations: Improving the access process for patients, clinicians and payers
Seth J. Baum et al.
CLINICAL CARDIOLOGY (2017)
Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1
Brennan K. Smith et al.
DIABETES (2016)
Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
Stephen L. Pinkosky et al.
NATURE COMMUNICATIONS (2016)
Effect of Targeting Inflammation With Salsalate The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins
Thomas H. Hauser et al.
JAMA CARDIOLOGY (2016)
Salicylate improves macrophage cholesterol homeostasis via activation of Ampk
Morgan D. Fullerton et al.
JOURNAL OF LIPID RESEARCH (2015)
An Overview of the New Frontiers in the Treatment of Atherogenic Dyslipidemias
F. H. Rached et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes
Joshua I. Barzilay et al.
DIABETES CARE (2014)
Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience
Warner M. Mampuya et al.
AMERICAN HEART JOURNAL (2013)
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Morgan D. Fullerton et al.
NATURE MEDICINE (2013)
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
Clinton S. Robbins et al.
NATURE MEDICINE (2013)
AMPK: mediating the metabolic effects of salicylate-based drugs?
Gregory R. Steinberg et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Macrophages in atherosclerosis: a dynamic balance
Kathryn J. Moore et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Inflammation in Atherosclerosis
Peter Libby
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes A Randomized Trial
Allison B. Goldfine et al.
ANNALS OF INTERNAL MEDICINE (2010)
AMPK beta 1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance
Nicolas Dzamko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes
Josef Ecker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Swapnil N. Rajpathak et al.
DIABETES CARE (2009)
Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin
Karel Otero et al.
NATURE IMMUNOLOGY (2009)
Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
Allison B. Goldfine et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2008)
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Amy Fleischman et al.
DIABETES CARE (2008)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ
MS Yuan et al.
SCIENCE (2001)
Inhibition of IκB kinase activity by sodium salicylate in vitro does not reflect its inhibitory mechanism in intact cells
D Alpert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)